首页> 外文期刊>International archives of occupational and environmental health: Internationales Archiv fur Arbeits- und Umweltmedizin >Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization.
【24h】

Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization.

机译:谷胱甘肽S-转移酶M1和T1的纯合基因缺失与硫柳汞致敏有关。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Thimerosal is an important preservative in vaccines and ophthalmologic preparations. The substance is known to be a type IV sensitizing agent. High sensitization rates were observed in contact-allergic patients and in health care workers who had been exposed to thimerosal-preserved vaccines. There is evidence for the involvement of the glutathione system in the metabolism of thimerosal or its decomposition products (organomercury alkyl compounds). Thus detoxification by polymorphically expressed glutathione S-transferases such as GSTT1 and GSTM1 might have a protective effect against sensitization by these substances. METHODS: To address this question, a case control study was conducted, including 91 Central European individuals with a positive patch-test reaction to thimerosal. This population was compared with 169 healthy controls and additionally with 114 individuals affected by an allergy against para-substituted aryl compounds. The latter population was included in order to test whether possible associations were due to substance-specific effects, or were a general feature connected with type IV immunological diseases. Homozygous deletions of GSTT1 and GSTM1 were determined by polymerase chain reaction. RESULTS: Glutathione S-transferase M1 deficiency was significantly more frequent among patients sensitized to thimerosal (65.9%, P = 0.013) compared with the healthy control group (49.1%) and the "para-compound" group (48%, P = 0.034). Glutathione S-transferase T1 deficiency in the thimerosal/mercury group (19.8%) was barely elevated versus healthy controls (16.0%) and the "para-compound" group (14.0%). The combined deletion (GSTT1-/GSTM1-) was markedly more frequent among thimerosal-sensitized patients than in healthy controls (17.6% vs. 6.5%, P = 0.0093) and in the "para-compound" group (17.6% vs. 6.1%, P =0.014), revealing a synergistic effect of these enzyme deficiencies (healthy controls vs. thimerosal GSTM1 negative individuals, OR = 2.0 [CI = 1.2-3.4], GSTT1-, OR = 1.2 [CI = 0.70-2.1], GSTM1/T1-, OR = 3.1 [CI = 1.4-6.5]). CONCLUSIONS: Since the glutathione-dependent system was repeatedly shown to be involved in the metabolism of thimerosal decomposition products, the observed association may be of functional relevance.
机译:目的:硫柳汞是疫苗和眼科制剂中的重要防腐剂。已知该物质是IV型敏化剂。在接触过敏的患者和接触硫柳汞保存的疫苗的医护人员中观察到高的致敏率。有证据表明谷胱甘肽系统参与硫柳汞或其分解产物(有机汞烷基化合物)的代谢。因此,通过多态表达的谷胱甘肽S-转移酶(例如GSTT1和GSTM1)进行的解毒可能对这些物质致敏具有保护作用。方法:为解决这个问题,进行了一项病例对照研究,其中包括91名对硫柳汞的斑贴试验阳性的中欧个体。将该人群与169名健康对照者以及另外114名对对位取代的芳基化合物过敏的个体进行了比较。为了检验可能的关联是由于物质特异性作用还是与IV型免疫疾病有关的一般特征,纳入了后者。通过聚合酶链反应确定GSTT1和GSTM1的纯合缺失。结果:与健康对照组(49.1%)和“对-化合物”组(48%,P = 0.034)相比,对硫柳汞敏感的患者中谷胱甘肽S-转移酶M1缺乏症的发生率明显更高(65.9%,P = 0.013)。 )。硫柳汞/汞组(19.8%)的谷胱甘肽S-转移酶T1缺乏症与健康对照组(16.0%)和“对位化合物”组(14.0%)相比几乎没有升高。在硫柳汞致敏的患者中,组合缺失(GSTT1- / GSTM1-)的发生率明显高于健康对照组(17.6%vs. 6.5%,P = 0.0093)和“对位化合物”组(17.6%vs. 6.1)。 %,P = 0.014),表明这些酶缺乏症具有协同作用(健康对照与硫柳汞GSTM1阴性个体,OR = 2.0 [CI = 1.2-3.4],GSTT1-,OR = 1.2 [CI = 0.70-2.1], GSTM1 / T1-,或= 3.1 [CI = 1.4-6.5])。结论:由于谷胱甘肽依赖性系统反复显示参与硫柳汞分解产物的代谢,因此观察到的关联可能与功能有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号